Impact of Surgical and Immunological Parameters in Pediatric Liver Transplantation: A Multivariate Analysis in 500 Consecutive Recipients of Primary Grafts

Annals of Surgery

Volumn 239, Issue 2, 2004, Pages 272-280

  Evrard, Veerle ^a   Otte, Jean Bernard ^a   Sokal, Etienne ^a   Rochet, Jean Stéphan ^a   Haccourt, Fabian ^a   Gennari, Fabrizio ^a   Latinne, Dominique ^a   Jamart, Jacques ^a   Reding, Raymond ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYA ME; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; UNCLASSIFIED DRUG;

ADOLESCENT; AGE; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; CANCER SURGERY; CHILD; CHILDHOOD CANCER; CORRELATION ANALYSIS; CROSS REACTION; DONOR; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LIVER CANCER; LIVER FAILURE; LIVER TRANSPLANTATION; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; VALIDATION PROCESS;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0842305750     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000108681.24374.02     Document Type: Article

References (24)

1. McDiarmid SV, Davies DB, Edwards EB. Improved graft survival of pediatric liver recipients transplanted with pediatric-aged liver donors. Transplantation. 2000;70:1283-1291.
2. Otte JB, de Ville de Goyet J, Reding R, et al. Pediatric liver transplantation: from the full-size liver graft to reduced, split, and living related liver transplantation. Pediatr Surg Int. 1998;13:308-318.
3. Pediatric liver transplantation registry. Studies of Pediatric Liver Transplantation (SPLIT): year 2000 outcomes. Transplantation. 2001;72:463-476.
4. McDiarmid SV. Management of the pediatric liver transplant patient. Liver Transpl. 2001;7:S77-S86.
5. Goss JA, Shackleton CR, McDiarmid SV, et al. Long-term results of pediatric liver transplantation: an analysis of 569 transplants. Ann Surg. 1998;228:411-420.
6. Reding R, de Ville de Goyet J, Delbeke I, et al. Pediatric liver transplantation with cadaveric or living related donors: comparative results in 90 elective recipients of primary grafts. J Pediatr. 1999;134:280-286.
7. Reding R, Gennari F, Janssen M, et al. The pediatric liver transplant program at the Université Catholique de Louvain, Cliniques Saint-Luc, Brussels: overall results in 444 children (1984-1997). Acta Gastroenterol Belg. 1999;62:285-289.
8. Sokal EM, Veyckemans F, de Ville de Goyet J, et al. Liver transplantation in children less than 1 year of age. J Pediatr. 1990;117:205-210.
9. Reding R, Feyaerts A, Vraux H, et al. Prophylactic immunosuppression with anti-interleukin-2 receptor monoclonal antibody LO-Tact-1 versus OKT3 in liver allografting. A two-year follow-up study. Transplantation. 1996;61:1406-1409.
10. Hubscher SG, Clements D, Elias E, et al. Biopsy findings in cases of rejection of liver allograft. J Clin Pathol. 1985;38:1366-1373.
11. Starzl TE, Koep LJ, Schroter GP, et al. Liver replacement for pediatric patients. Pediatrics. 1979;63:825-829.
12. de Ville de Goyet J, Hausleithner V, Reding R, et al. Impact of innovative techniques on the waiting list and results in pediatric liver transplantation. Transplantation. 1993;56:1130-1136.
13. Whitington PF. Living donor liver transplantation: ethical considerations. J Hepatol. 1996;24:625-627.
14. Reding R, Wallemacq P, Moulin D, et al. Early hepatocyte, endothelial, and bile duct cell injury after pediatric liver transplantation from cadaveric or living-related donors. Transplantation. 1998;65:681-685.
15. Smets F, Bodeus M, Goubau P, et al. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients 4. J Hepatol. 2000;32:100-104.
16. Kelly D, Jara P, Rodeck B, et al. Tacrolimus dual therapy versus cyclosporin-microemulsion triple therapy in pediatric liver transplantation: results from a multicentre randomized trial. Am J Transplant. 2002;2:351.
17. Reding R, Veyckemans F, de Ville de Goyet J, et al. ABO-incompatible orthotopic liver allografting in urgent indications. Surg Gynecol Obstet. 1992;174:59-64.
18. Gunson BK, Hathaway M, Buckels JA, et al. HLA matching in liver transplantation: a retrospective analysis. Transplant Proc. 1992;24:2434-2435.
19. Nikaein A, Backman L, Jennings L, et al. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and crossmatching. Transplantation. 1994;58:786-792.
20. Thorogood J. Relationship between HLA compatibility and first liver allograft survival. l'ESPRIT Study Group. Transplant Proc. 1993;25:2655-2656.
21. Markus BH, Duquesnoy RJ, Gordon RD, et al. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation. 1988;46:372-377.
22. Francavilla R, Hadzic N, Underhill J, et al. Role of HLA compatibility in pediatric liver transplantation. Transplantation. 1998;66:53-58.
23. Hathaway M, Gunson BK, Keogh AC, et al. A positive crossmatch in liver transplantation-no effect or inappropriate analysis? A prospective study. Transplantation. 1997;64:54-59.
24. Starzl TE, Murase N. Microchimerism, macrochimerism, and tolerance. Clin Transplant. 2000;14:351-354.